Education
About Us
Working with TipRanks
Follow Us
SCHD - ETF AI Analysis
Top Page
Schwab US Dividend Equity ETF (SCHD)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, like AbbVie and Amgen, have delivered strong year-to-date performance, supporting the fund's overall returns.
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective compared to similar funds.
Sector Diversification
The fund is spread across multiple sectors, including Consumer Defensive, Energy, and Health Care, reducing reliance on any single industry.
Negative Factors
Geographic Concentration
The ETF is heavily focused on U.S. companies, with minimal exposure to international markets, limiting global diversification.
Recent Underperformance
The fund has shown negative performance over the past month, three months, and year-to-date, which may concern investors seeking growth.
Lagging Holdings
Some top holdings, like Merck and Home Depot, have underperformed year-to-date, potentially dragging on the fund's overall returns.
SCHD vs. SPDR S&P 500 ETF (SPY)
AUM71.29B
RegionNorth America
Expense Ratio0.06%
Beta0.58
IssuerSchwab
Inception DateOct 20, 2011
Dividend Yield3.77%
Asset ClassEquity
Index TrackedDow Jones U.S. Dividend 100
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume14,545,790
30 Day Avg. Volume17,728,200
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.86Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering99
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCHD Summary
The Schwab US Dividend Equity ETF (SCHD) is an investment fund that focuses on U.S. companies with strong dividend payouts, following the Dow Jones U.S. Dividend 100 Index. It includes well-known companies like PepsiCo and Coca-Cola, offering exposure to sectors such as consumer goods, healthcare, and energy. Investors might consider SCHD for steady income through dividends and potential long-term growth. However, new investors should be aware that the ETF’s performance can fluctuate with the overall stock market, especially since it heavily relies on dividend-paying companies.
How much will it cost me?SCHD has an expense ratio of 0.06%, which means you’ll pay $0.60 per year for every $1,000 invested. This is lower than average because SCHD is passively managed, tracking an index rather than relying on active stock picking.
What would affect this ETF?SCHD's focus on U.S. companies with strong dividend performance could benefit from stable economic growth and favorable corporate earnings, particularly in sectors like Consumer Defensive and Health Care, which are less sensitive to economic downturns. However, rising interest rates or regulatory changes affecting dividend payouts could negatively impact its performance, especially in sectors like Energy and Financials. Additionally, shifts in consumer spending or geopolitical tensions could influence the top holdings, such as PepsiCo, Chevron, and Lockheed Martin.
SCHD Top 10 Holdings
SCHD’s portfolio leans heavily on U.S. dividend stalwarts, with a notable tilt toward healthcare and consumer defensive sectors. AbbVie and Amgen are rising stars, benefiting from strong earnings and growth in key therapeutic areas, while Merck’s performance has been steady but cautious. On the consumer side, Coca-Cola is holding its ground, but PepsiCo has been lagging, weighed down by mixed technical signals. Energy names like Chevron are showing mixed results, reflecting sector volatility. Overall, the fund’s sector diversity provides balance, but healthcare and consumer defensive stocks are driving much of the action.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Merck & Company | 4.74% | $3.38B | $247.51B | -2.05% | 80 Outperform | |
| Amgen | 4.65% | $3.32B | $177.64B | 16.49% | 77 Outperform | |
| Cisco Systems | 4.61% | $3.29B | $308.07B | 34.30% | 77 Outperform | |
| AbbVie | 4.27% | $3.04B | $399.57B | 27.01% | 66 Neutral | |
| Bristol-Myers Squibb | 4.27% | $3.04B | $106.16B | -11.10% | 78 Outperform | |
| Coca-Cola | 4.06% | $2.89B | $301.11B | 11.67% | 76 Outperform | |
| Conocophillips | 3.96% | $2.82B | $115.77B | -9.26% | 78 Outperform | |
| PepsiCo | 3.90% | $2.78B | $198.29B | -8.89% | 78 Outperform | |
| Verizon | 3.81% | $2.72B | $175.78B | -2.36% | 81 Outperform | |
| Chevron | 3.80% | $2.71B | $302.03B | -5.28% | 71 Outperform |
SCHD Technical Analysis
Positive
―
Price Trends
27.07
Positive
27.07
Positive
26.63
Positive
Market Momentum
0.18
Negative
54.57
Neutral
58.18
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SCHD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 27.31, equal to the 50-day MA of 27.07, and equal to the 200-day MA of 26.63, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 54.57 is Neutral, neither overbought nor oversold. The STOCH value of 58.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SCHD.
SCHD Peer Comparison
Comparison Results
Performance Comparison
SCHD
Schwab US Dividend Equity ETF
27.46
0.00
0.00%
VYM
Vanguard High Dividend Yield Index ETF
―
―
―
DVY
iShares Select Dividend ETF
―
―
―
SDY
SPDR S&P Dividend ETF
―
―
―
HDV
iShares Core High Dividend ETF
―
―
―
FVD
First Trust Value Line Dividend Index Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents